About Investment Banking

Our team of experienced investment bankers focuses on building long-term relationships with corporates, investors, and financial sponsors who can look to us for advice on how to support their business objectives through all market cycles.

We provide a wide breadth of products and services, including equity and debt capital markets and advisory, as well as special purpose acquisition companies (SPACs), convertible notes, and ATM offerings. With access to a broad institutional investor base, our 200-person salesforce can match differentiated demand across all major global markets.

Guided by a growth mindset, we’ve made significant investments in our human capital and have built a powerhouse team, including across the healthcare and technology sectors. With their specialized expertise, Cantor can provide bulge-bracket capabilities with a personalized experience that always puts our clients first.

0+

Transactions сompleted since 2016

$0 billion+

Raised since 2016

At a Glance

Our Capabilities

Equity Capital Markets

Equity Capital Markets

Our expanding Equity Capital Markets (ECM) practice provides a full range of capital markets capabilities, including:

  • Initial public offerings (IPOs)
  • Confidentially marketed public offerings (CMPOs)
  • Marketed follow-on offerings
  • Registered direct transactions (RDs)
  • Private investment in public equity (PIPEs)
  • Bought deals

With a team of more than 200 equity sales and trading professionals spanning trading hubs in New York, London, and Hong Kong, we give our clients access to more than 7,000 institutional investor accounts. Cantor combines bulge bracket distribution capabilities with connectivity to middle market institutional investors to provide differentiated demand.

ATMs

ATMs

We are a leader in the ATM market, with programs filed in healthcare, technology, metals and mining, crypto, closed-end-funds, and REITs. Our team has executed more ATM offerings than any other broker dealer since 2001, maintaining a top-three ranking in healthcare and metals and mining, and we continue to expand our business in the technology sector. As one of the early pioneers in the ATM market, our experience and expertise have consistently helped our clients raise the capital they need on the terms they want.

Mergers & Acquisitions

Mergers & Acquisitions

We are an independent, trusted global M&A advisor with deep sector expertise, insights, and execution capabilities. We partner with clients across a wide range of advisory services, including mergers and acquisitions, divestitures, strategic partnerships, spin-offs, joint ventures, fairness opinions, and shareholder advisory.

Our team of dedicated professionals has a significant track record of providing exceptional results for our clients. Management teams and Boards look to us for our thoughtful, tailored advice when navigating their most important strategic decisions.

Debt Capital Markets

Debt Capital Markets

Cantor’s debt advisory team has extensive experience executing financings across a range of different situations and structures and can customize its approach depending on the borrower’s needs. Our network of long-standing relationships with capital providers, combined with our deep sector expertise within healthcare and technology, sets us apart and uniquely positions us to help our clients raise non-dilutive capital in any market condition.

Our debt advisory team works hand in hand with our industry bankers to deliver a streamlined experience, and our high-touch approach provides our clients with optimal transaction structuring and execution.

Debt Structures

  • Venture debt
  • Structured debt
  • Royalty financing
  • Product/clinical trial finance
  • Asset-based loans
  • Unitranche loans
  • Second-lien/mezzanine
  • Preferred equity

Situations

  • Growth capital
  • R&D/product finance
  • Acquisition financing
  • Refinancing
  • Dividend recap
  • Management buyout
  • Special situations financing

SPACs

SPACs

Cantor’s market-leading special purpose acquisition company (SPAC) practice provides a comprehensive suite of advisory and capital raising solutions for SPAC sponsors and private companies seeking to go public. Leveraging one of the largest and most experienced teams on Wall Street, we have demonstrated an unwavering commitment to clients across market cycles and regulatory environments. With the global reach and relationships of a money center bank and the agility of a boutique, Cantor remains at the forefront of developing innovative structures and approaches that enhance the appeal of SPACs for both private companies and investors.

Convertibles

Convertibles

Our award-winning convertibles practice is a leader in global convertibles issuance, boasting more than 25 years of market experience. We’ve helped borrowers raise more than $125 billion of equity-linked capital through both convertible bond and convertible preferred offerings.

With access to a wide network of institutional investors, we help companies raise funds with nondilutive solutions, while also providing greater funding flexibility at a lower cost than traditional debt markets.

Our Sectors

With deep sector knowledge and strong buy-side relationships, Cantor provides a full suite of investment banking services to healthcare businesses, supporting them through key strategic decisions in all market conditions. The team’s key focus areas include biotech, medical devices, healthcare services/facilities, pharmacy services, and healthcare IT.

Our award-winning global power, energy transition and infrastructure team has more than 20 years of experience advising a broad range of businesses on M&A, capital raising, project financing, and more. The team focuses on renewable and conventional power businesses and projects, companies across the energy transition value chain, as well as a diverse range of infrastructure businesses and projects spanning transport, telecoms, and utilities.

Our global technology team is the fastest growing on our investment banking platform, offering M&A, ECM, private placement, and debt advisory capabilities to companies across a wide array of technology sub-sectors, including software, industrial technologies, electronics, internet and digital media, tech-enabled services, and fintech. With deep domain expertise, our team ensures both early stage and established tech companies have the support they need.

With more than 25 years of experience, the team provides a number of services across financial advisory, equity capital markets, equity-linked capital markets, and debt capital markets with a focus on various commodities, including precious metals, base metals, uranium, battery materials, and other specialty metals and minerals. The team supports companies from exploration through production and is also active across numerous publicly traded physical commodity funds. The team has strong expertise in cross-border transactions, and regularly works with issuers listed in the US, Canada, the UK, and Australia.

Our Leadership

Sage Kelly

Senior Managing Director
Global Head of Investment Banking

Sage Kelly

Sage Kelly

Senior Managing Director
Global Head of Investment Banking

Sage Kelly is a Senior Managing Director and Global Head of Investment Banking at Cantor Fitzgerald & Co.

Mr. Kelly has 30 years of experience in investment banking. Prior to joining Cantor, he served as the Head of Healthcare Investment Banking at Jefferies from 2009 to 2015. Before that, Mr. Kelly was a Managing Director at UBS, where he worked from 1999 to 2009, and at Citibank in the Healthcare Investment Banking Group from 1994 to 1999.

Mr. Kelly also spent three years working in the biotechnology industry for Genetics Institute.

Mr. Kelly is a graduate of Boston College and holds a bachelor’s degree in finance, economics, and chemistry.

Recent Transactions

Healthcare

$165,000,000

Follow-on Offering

Joint Bookrunner
December 2024

Healthcare

$100,000,000

Follow-on Offering

Joint Bookrunner
December 2024

Healthcare

$402,500,000

Follow-on Offering

Joint Bookrunner
December 2024

Technology

$600,000,000

Convertible Senior Notes

Active Bookrunner
December 2024

Technology

$500,000,000

$500,000,000

Joint Agent
December 2024

Technology

$125,000,000

Follow-on Offering

Active Bookrunner
December 2024

Technology

$625,000,000

Convertible Senior Notes

Joint Bookrunner
December 2024

SPACs

$496,300,000

Enterprise Value

SPAC IPO Underwriter
November 2024

Recent Transactions

Healthcare

$165,000,000

Follow-on Offering

Joint Bookrunner
December 2024

Healthcare

$100,000,000

Follow-on Offering

Joint Bookrunner
December 2024

Healthcare

$402,500,000

Follow-on Offering

Joint Bookrunner
December 2024

Technology

$600,000,000

Convertible Senior Notes

Active Bookrunner
December 2024

Technology

$500,000,000

$500,000,000

Joint Agent
December 2024

Technology

$125,000,000

Follow-on Offering

Active Bookrunner
December 2024

Technology

$625,000,000

Convertible Senior Notes

Joint Bookrunner
December 2024

SPACs

$496,300,000

Enterprise Value

SPAC IPO Underwriter
November 2024

Healthcare

$80,000,000

PIPE

Joint Placement Agent
November 2024

Technology

$3,000,000,000

Convertible Senior Notes

Active Bookrunner
November 2024

Technology

$1,000,000,000

Convertible Senior Notes

Joint Bookrunner
November 2024

Technology

$70,000,000

At-The-Market Offering

Sole Agent
November 2024

Healthcare

$345,000,000

Follow-on Offering

Joint Bookrunner
October 2024

Healthcare

$331,200,000

Initial Public Offering

Joint Bookrunner
October 2024

Healthcare

$84,750,000

Follow-on Offering & Concurrent PIPE

Joint Bookrunner
October 2024

Healthcare

$500,000,000

Follow-on Offering

Joint Bookrunner
October 2024

Technology

$500,000,000

Convertible Senior Notes

Solo Bookrunner
October 2024

Technology

$450,000,000

Convertible Senior Notes

Joint Bookrunner
October 2024

Technology

$21,000,000,000

At-The-Market Offering

Joint Agent
October 2024

SPACs

$200,000,000

(NASDAQ: CCIRU)

Initial Public Offering
Solo Bookrunner
October 2024

SPACs

$230,000,000

(NASDAQ: LPBBU)

Initial Public Offering
Solo Bookrunner
October 2024

Technology

$150,000,000

At-The-Market Offering

Sole Agent
October 2024

Technology

$100,000,000

Follow-on Offering

Sole Bookrunner
October 2024

Technology

$875,000,000

Convertible Senior Notes

Co-Manager
September 2024

Technology

$50,000,000

At-The-Market Offering

Joint Agent
September 2024

Healthcare

$315,000,000

Initial Public Offering

Joint Bookrunner
September 2024

SPACs

$135,000,000

Enterprise Value

SPAC IPO Underwriter
Pending

SPACs

$240,000,000

Enterprise Value

SPAC IPO Underwriter
Pending

SPACs

$870,000,000

Enterprise Value

SPAC IPO Underwriter
Pending

Technology

$600,000,000

At-The-Market Offering

Joint Agent
September 2024

Technology

$400,000,000

At-The-Market Offering

Joint Agent
September 2024

Technology

$300,000,000

Convertible Senior Notes

Joint Bookrunner
August 2024

Technology

$460,000,000

Convertible Senior Notes

Joint Bookrunner
August 2024

Technology

$300,000,000

Convertible Senior Notes

Joint Bookrunner
August 2024

Technology

$750,000,000

At-The-Market Offering

Joint Agent
August 2024

Healthcare

$60,000,000

Follow-On Offering

Lead Left Bookrunner
August 2024

Healthcare

$345,138,000

Follow-on Offering

Joint Bookrunner
August 2024

SPACs

$287,500,000

(NASDAQ: MBAVU)

Initial Public Offering
Sole Bookrunner
August 2024

SPACs

$253,000,000

(NASDAQ: VACHU)

Initial Public Offering
Sole Bookrunner
August 2024

SPACs

$100,000,000

(NASDAQ: CEP)

Initial Public Offering
Sole Bookrunner
August 2024

SPACs

$230,000,000

(NASDAQ: HONDU)

Initial Public Offering
Sole Bookrunner
August 2024

SPACs

$1,600,000,000

Enterprise Value

Financial Advisor
August 2024

Technology

Financial Advisor
July 2024

Healthcare

$55,000,000

Follow-on Offering

Joint Bookrunner
July 2024

Healthcare

$78,900,000

PIPE

Joint Placement Agent
July 2024

Healthcare

$167,000,000

Initial Public Offering

Joint Bookrunner
July 2024

SPACs

$230,000,000

(NASDAQ: SIMAU)

Initial Public Offering
Sole Bookrunner
July 2024

SPACs

$230,000,000

(NASDAQ: LPAUU)

Initial Public Offering
Sole Bookrunner
July 2024

Healthcare

$50,000,000

Follow-on Offering

Joint Bookrunner
June 2024

Healthcare

$67,143,000

Follow-on Offering

Joint Bookrunner
June 2024

Healthcare

$461,000,000

Follow-on Offering

Joint Bookrunner
June 2024

Healthcare

$82,260,000

Follow-on Offering

Joint Bookrunner
June 2024

Healthcare

$250,000,000

Initial Public Offering

Joint Bookrunner
June 2024

Metals & Mining

US$100.0 Million

Initial Public Offering

Trust Units
Co-Lead Underwriter
June 2024

Metals & Mining

US$15.0 Million

Overnight Marketed Best
Efforts Private Placement

Common Shares
Sole Bookrunner
June 2024

Metals & Mining

Up to C$20.0 Million

Controlled Equity Offering

Common Shares
Sole Agent
June 2024

Metals & Mining

US$22.0 Million

Marketed Best Efforts Private Placement

Flow-Through Shares
Sole Bookrunner
June 2024

SPACs

$230,000,000

(NASDAQ: GRAF/U)

Initial Public Offering
Sole Bookrunner
June 2024

SPACs

$287,500,000

(NASDAQ: ALFUU)

Initial Public Offering
Sole Bookrunner
June 2024

SPACs

$230,000,000

(NASDAQ: CUBWU)

Initial Public Offering
Sole Bookrunner
June 2024

Technology

$500,000,000

At The Market Offering

Sales Agent
May 2024

Technology

$200,000,000

At The Market Offering

Sales Agent
May 2024

Technology

$200,000,000

At The Market Offering

Sales Agent
May 2024

Technology

$94,200,000

Advisor to Seller
May 2024

Healthcare

$158,700,000

Follow-on Offering

Joint Bookrunner
May 2024

Healthcare

$105,000,000

Follow-on Offering

Joint Bookrunner
May 2024

Technology

$150,000,000

At-The-Market Offering

Sole Agent
May 2024

Technology

$1,400,000,000

Convertible Senior Notes

Bookrunner
May 2024

Technology

€45,000,000

NAV Loan

Sole Placement Agent
May 2024

Technology

$150,000,000

Private Placement

Sole Placement Agent
May 2024

Healthcare

Exclusive Financial Advisor May 2024

SPACs

$287,500,000

(NASDAQ: GPATU)

Initial Public Offering
Sole Bookrunner
May 2024

Healthcare

$112,500,000

PIPE

Joint Placement Agent April 2024

Technology

$100,000,000

At-the-Market Offering

Sole Agent April 2024

Healthcare

$264,500,000

Follow-on Offering

Joint Bookrunner
April 2024

Technology

$832,000,000

Initial Public Offering

Co-Manager
April 2024

Healthcare

Exclusive Financial Advisor
April 2024

Technology

$150,000,000

Convertible Senior Notes

Sole Bookrunner
April 2024

Healthcare

Financial Advisor
April 2024

SPACs

$1,441,000,000

Enterprise Value

SPAC IPO Underwriter
April 2024

SPACs

$568,200,000

Enterprise Value

SPAC IPO Underwriter
April 2024

Healthcare

$287,500,000

Follow-on Offering

Joint Bookrunner March 2024

Healthcare

$175,000,000

Follow-on Offering & PIPE

Joint Bookrunner March 2024

ATM

$150,000,000

Equity Offering

March 2024

ATM

$75,000,000

Equity Offering

March 2024

Technology

$50,000,000

At-the-Market Offering

Joint Agent March 2024

Technology

$604,700,000

Convertible Senior Notes

Co-Manager March 2024

Metals & Mining

Up to $150.0 Million

Controlled Equity Offering

Common Shares
Lead Left Agent
March 2024

SPACs

$1,189,000,000

Enterprise Value

SPAC IPO Underwriter
March 2024

Healthcare

$160,121,000

Follow-on Offering

Joint Bookrunner February 2024

Healthcare

$341,000,000

Follow-on Offering

Joint Bookrunner February 2024

Healthcare

$400,208,000

PIPE

Joint Placement Agent February 2024

Healthcare

$460,500,000

Follow-on Offering

Joint Bookrunner February 2024

ATM

$40,000,000

Equity Offering

February 2024

ATM

$100,000,000

Equity Offering

February 2024

ATM

$300,000,000

Equity Offering

February 2024

ATM

$250,000,000

Equity Offering

February 2024

ATM

$100,000,000

Equity Offering

February 2024

Technology

$75,000,000

At-the-Market Offering

Sole Agent February 2024

Metals & Mining

$12.1 CAD Million

Overnight Marketed Best Efforts Offering

Units
Sole Bookrunner
February 2024

Healthcare

Financial Advisor
February 2024

SPACs

$838,000,000

Enterprise Value

SPAC IPO Underwriter
February 2024

SPACs

$112,000,000

Enterprise Value

SPAC IPO Underwriter
February 2024

SPACs

$1,200,000,000

Enterprise Value

SPAC IPO Underwriter
February 2024

Healthcare

$150,000,000

Follow-on Offering

Joint Bookrunner January 2024

Healthcare

$109,000,000

PIPE

Joint Lead Placement Agent January 2024

Healthcare

$75,000,000

Follow-on Offering

Sole Bookrunner January 2024

Healthcare

$437,000,000

Initial Public Offering

Joint Bookrunner
January 2024

ATM

$25,000,000

Equity Offering

January 2024

ATM

$20,000,000

Equity Offering

January 2024

Metals & Mining

Up to $1.0 Billion

Controlled Equity Offering

Trust Units
Lead Left Agent
January 2024

Healthcare

$241,500,000

Follow-on Offering

Lead Left Bookrunner
January 2024

Healthcare

$862,500,000

Follow-on Offering

Joint Bookrunner
January 2024

Power Energy & Infrastructure

Undisclosed

Preferred Equity Investment and Project Capital Injection in Holu Hou Energy LLC by Irradiant Partners, LP

Sole Financial Advisor
January 2024

SPACs

$111,000,000

Enterprise Value

SPAC IPO Underwriter
January 2024

Healthcare

$230,000,000

Follow-on Offering

Joint Bookrunner December 2023

Healthcare

$172,500,000

Follow-on Offering

Joint Bookrunner December 2023

ATM

$75,000,000

Equity Offering

December 2023

ATM

$170,000,000

Equity Offering

December 2023

Metals & Mining

$16.1 Million

Marketed Best Efforts Private Placement

Flow-Through Shares
Lead Left Bookrunner
December 2023

Metals & Mining

Up to $50.0 CAD Million

Controlled Equity Offering

Common Shares
Co-Lead Agent
December 2023

Healthcare

$230,500,000

Follow-on Offering

Joint Bookrunner November 2023

ATM

$96,800,000

Equity Offering

November 2023

ATM

$150,000,000

Equity Offering

November 2023

ATM

$59,000,000

Equity Offering

November 2023

ATM

$262,800,000

Equity Offering

November 2023

ATM

$200,000,000

Equity Offering

November 2023

ATM

$65,100,000

Equity Offering

November 2023

Technology

$75,000,000

At-the-Market Offering

Sole Agent November 2023

Metals & Mining

Up to $125.0 Million

Controlled Equity Offering

Trust Units
Lead Left Agent
November 2023

Healthcare

$63,250,000

Follow-on Offering

Joint Bookrunner October 2023

Metals & Mining

$55.1 Million

Bought Deal

Common Shares
Sole Bookrunner
October 2023

Healthcare

$258,750,000

Follow-on Offering

Joint Bookrunner September 2023

Healthcare

$129,000,000

Follow-on Offering & PIPE

Joint Bookrunner September 2023

ATM

$50,000,000

Equity Offering

September 2023

Technology

$50,000,000

At-the-Market Offering

Sole Agent September 2023

Technology

$425,000,000

Convertible Notes

Co-Manager September 2023

Technology

$25,000,000

Convertible Preferred Stock

Joint Placement Agent September 2023

Metals & Mining

Up to $125.0 Million

Controlled Equity Offering

Trust Units
Lead Left Agent
September 2023

Metals & Mining

$125.0 Million

Confidentially Marketed Accelerated Book Build Offering

Common Shares
Lead Left Bookrunner
September 2023

ATM

$75,000,000

Equity Offering

August 2023

ATM

$200,000,000

Equity Offering

August 2023

ATM

$75,000,000

Equity Offering

August 2023

ATM

$150,000,000

Equity Offering

August 2023

ATM

$50,000,000

Equity Offering

August 2023

ATM

$30,000,000

Equity Offering

August 2023

ATM

$150,000,000

Equity Offering

August 2023

ATM

$35,000,000

Equity Offering

August 2023

Technology

$250,000,000

At-the-Market Offering

Joint Agent August 2023

Technology

$13,800,000

At-the-Market Offering

Sole Agent August 2023

Technology

$750,000,000

At-the-Market Offering

Joint Agent August 2023

Technology

$250,000,000

At-the-Market Offering

Joint Agent August 2023

Technology

$65,000,000

Follow-On Offering

Joint Bookrunner August 2023

Technology

$100,000,000

At-the-Market Offering

Sole Agent August 2023

Technology

$20,000,000

PIPE

Sole Placement Agent August 2023

Technology

$200,000,000

At-the-Market Offering

Joint Agent August 2023

Metals & Mining

$6.9 CAD Million

Bought Deal

Units
Joint Bookrunner
August 2023

Metals & Mining

$8.0 CAD Million

Bought Deal Private Placement

Units
Sole Bookrunner
August 2023

Metals & Mining

$26.9 Million

Registered Direct Offering

Units
Financial Advisor
August 2023

ATM

$24,000,000

Equity Offering

July 2023

Technology

$150,000,000

At-the-Market Offering

Sole Agent July 2023

Metals & Mining

Up to $50.0 Million

Controlled Equity Offering

Common Shares
Co-Lead Agent
July 2023

Healthcare

$97,800,000

Follow-on Offering

Joint Bookrunner June 2023

Healthcare

$258,800,000

Follow-on Offering

Joint Bookrunner June 2023

ATM

$100,000,000

Equity Offering

June 2023

ATM

$40,000,000

Equity Offering

June 2023

Technology

$52,500,000

Follow-On Offering

Financial Advisor June 2023

Technology

$165,000,000

ABL & Senior Secured Term Loan

Sole Placement Agent June 2023

Technology

$25,000,000

Registered Direct Offering

Joint Placement Agent June 2023

Metals & Mining

Up to $25.0 Million

Controlled Equity Offering

Common Shares
Lead Left Agent
June 2023

Metals & Mining

Up to $40.0 Million

Controlled Equity Offering

Common Shares
Sole Agent
June 2023

Metals & Mining

Up to $70.0 Million

Controlled Equity Offering

Common Shares
Lead Left Agent
June 2023

Debt

$160,000,000

Synthetic Royalty + Equity

Sole Placement Agent May 2023

Healthcare

$185,000,000

PIPE

Joint Placement Agent May 2023

Healthcare

$65,000,000

PIPE

Joint Placement Agent May 2023

Healthcare

$50,000,000

PIPE

Lead Placement Agent May 2023

ATM

$150,000,000

Equity Offering

May 2023

ATM

$30,000,000

Equity Offering

May 2023

ATM

$80,400,000

Equity Offering

May 2023

ATM

$50,000,000

Equity Offering

May 2023

ATM

$63,900,000

Equity Offering

May 2023

ATM

$150,000,000

Equity Offering

May 2023

ATM

$40,000,000

Equity Offering

May 2023

ATM

$18,000,000

Equity Offering

May 2023

Metals & Mining

Up to $20.0 Million

Controlled Equity Offering

Common Shares
Sole Agent
May 2023

Metals & Mining

Up to $30.0 Million

Controlled Equity Offering

Common Shares
Sole Agent
May 2023

ATM

$50,000,000

Equity Offering

April 2023

ATM

$15,700,000

Equity Offering

April 2023

ATM

$150,000,000

Equity Offering

April 2023

ATM

$75,000,000

Equity Offering

April 2023

Technology

$200,000,000

At-the-Market Offering

Joint Agent April 2023

Technology

$100,000,000

Senior Secured Credit Facilities

Joint Placement Agent April 2023

Metals & Mining

Up to $250.0 Million

Controlled Equity Offering

Trust Units
Lead Left Agent
April 2023

Metals & Mining

Up to $1.0 Billion

Controlled Equity Offering

Trust Units
Lead Left Agent
April 2023

ATM

$300,000,000

Equity Offering

March 2023

ATM

$80,400,000

Equity Offering

March 2023

ATM

$100,000,000

Equity Offering

March 2023

ATM

$16,700,000

Equity Offering

March 2023

ATM

$150,000,000

Equity Offering

March 2023

ATM

$11,200,000

Equity Offering

March 2023

Healthcare

$230,000,000

Follow-on Offering

Joint Bookrunner February 2023

ATM

$150,000,000

Equity Offering

February 2023

ATM

$12,500,000

Equity Offering

February 2023

ATM

$70,000,000

Equity Offering

February 2023

ATM

$200,000,000

Equity Offering

February 2023

ATM

$17,000,000

Equity Offering

February 2023

Technology

$810,000,000

Acquisition Corp. Has Merged With Intuitive Machines

Advisor to Buyer February 2023

Metals & Mining

$51.0 Million

Senior Secured Convertible Notes Offering

Sole Agent
February 2023

Metals & Mining

$74.3 Million

Confidentially Marketed Accelerated Book Build Offering

Common Shares
Lead Left Bookrunner
February 2023

Metals & Mining

$120.0 Million

Sale of Alta Mesa ISR Project to Encore Energy

Financial Advisor
February 2023

Metals & Mining

Up to $1.3 Billion

Controlled Equity Offering

Trust Units
Lead Left Agent
February 2023

Metals & Mining

$34.5 CAD Million

Overnight Marketed Best Efforts Offering

Units
Co-Lead Underwriter
February 2023

Metals & Mining

$46.1 Million

Confidentially Marketed Best Efforts Offering

Units
Sole Bookrunner
February 2023

Debt

Undisclosed

Senior Secured Term Loan

Sole Placement Agent January 2023

Healthcare

$75,000,000

Follow-on Offering

Joint Bookrunner January 2023

ATM

$75,000,000

Equity Offering

January 2023

Metals & Mining

$10.9 CAD Million

Bought Deal

Units
Sole Bookrunner
January 2023

Metals & Mining

Up to $100.0 Million

Controlled Equity Offering

Common Shares
Lead Left Agent
January 2023

Contact

Investment Banking

For additional information on Cantor Investment Banking and how our platform can support your business, get in touch below.